Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Role of vitamin D in risk factors of patients with type 2 diabetes mellitus
Journal Information
Vol. 154. Issue 5.
Pages 151-156 (March 2020)
Share
Share
Download PDF
More article options
Visits
199
Vol. 154. Issue 5.
Pages 151-156 (March 2020)
Original article
Role of vitamin D in risk factors of patients with type 2 diabetes mellitus
Papel de la vitamina D en los factores de riesgo de los pacientes con diabetes mellitus tipo 2
Visits
199
Qingqing Zhanga,
Corresponding author
18061986120@189.cn

Corresponding author.
, Yucheng Wub, Yu Lua, Xiaoqiang Feia
a Department of Endocrinology, The Affiliated Taizhou People's Hospital of Nantong University, Taizhou 225300, Jiangsu, China
b Department of Cardiology, The Affiliated Taizhou People's Hospital of Nantong University, Taizhou 225300, Jiangsu, China
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (2)
Table 1. Clinical and laboratory characteristics in vitamin D sufficiency and vitamin D insufficiency group.
Table 2. Correlation coefficients of Lp-PLA2 with 25-(OH)D levels in vitamin D insufficiency and Vitamin D sufficiency group.
Show moreShow less
Additional material (1)
Abstract
Introduction and objectives

Previous observational studies have suggested that low vitamin D status is associated with high circulating C-reactive protein levels, as well as other plasma inflammatory cytokines. However, there is no study to explore the relationship between vitamin D status and Lp-PLA2, a new biomarker of vascular-specific inflammation. The aim of this study was to examine the association between vitamin D status and circulating Lp-PLA2 levels in subjects with type 2 diabetes mellitus.

Material and methods

This descriptive cross-sectional study enrolled diabetic subjects who underwent physical examination at Taizhou People's Hospital between August 2016 and January 2017. Blood pressure, anthropometry, metabolic profiles, serum 25(OH)D levels and Lp-PLA2 mass levels were measured in all participants.

Results

A total of 196 participants were recruited into this study. The vitamin D insufficiency group had higher serum LP-PLA2 levels than the vitamin D sufficiency group (t=−2.765, p=.005). A significant negative correlation was noted between Lp-PLA2 and 25(OH)D in the vitamin D insufficiency group (r=−0.364, p=0.009). However, no significant relationship between serum Lp-PLA2 concentration and 25(OH)D levels was observed in subjects with vitamin D sufficiency.

Conclusions

From this cohort of patients with type 2 diabetes, regardless of traditional cardiovascular risk factors, we observed a statistically significant inverse relation between Lp-PLA2 and 25(OH)D at levels <30ng/mL.

Keywords:
Vitamin D
Cardiovascular risk
Lipoprotein-associated phospholipase A2
Type 2 diabetes
Resumen
Introducción y objetivos

Los estudios observacionales previos han sugerido que la situación de los bajos niveles de la vitamina D está asociada a los altos niveles de la proteína C reactiva circulantes, así como a otras citoquinas inflamatorias en plasma. Sin embargo, no existe ningún estudio que explore la relación entre la situación de la vitamina D y la lipoproteína asociada a la fosfolipasa A2 (Lp-PLA2), un nuevo biomarcador de la inflamación específico vascular. El objetivo de este estudio fue examinar la asociación entre la situación de la vitamina D y los niveles circulantes de Lp-PLA2 en sujetos con diabetes mellitus tipo 2.

Material y métodos

Estudio transversal descriptivo que incluyó sujetos diabéticos que fueron sometidos a un examen físico en el Hospital popular de Taizhou entre agosto de 2016 y enero de 2017. Se midieron en todos los participantes la presión arterial, la antropometría, los perfiles metabólicos, el suero de 25 (OH) niveles séricos de vitamina D y los niveles de masa de Lp-PLA2.

Resultados

Un total de 196 participantes fueron reclutados para este estudio. El grupo de insuficiencia de la vitamina D reflejó unos niveles superiores de Lp-PLA2 que el grupo con suficiencia de vitamina D (T=−2,765; p=0,005). Se observó una correlación negativa significativa entre Lp-PLA2 y 25(OH)D en el grupo con insuficiencia de vitamina D (R=−0,364; p=0,009). Sin embargo, no se observó ninguna relación significativa entre la concentración sérica de Lp-PLA2 y 25(OH)D en sujetos con niveles de suficiencia de vitamina D.

Conclusiones

A partir de esta cohorte de pacientes con diabetes tipo 2, independientemente de los factores de riesgo cardiovascular, se observó una relación inversa entre Lp-PLA2, estadísticamente significativa, en los niveles de 25(OH)D<30ng/ml.

Palabras clave:
Vitamina D
Riesgo cardiovascular
Fosfolipasa A2 lipoproteína asociada
Diabetes tipo 2

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
Supplemental materials
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.medcle.2020.11.019
No mostrar más